Abstract
Homocysteine and asymmetric dimethylarginine (ADMA) affect nitric oxide (NO) concentration, thereby contributing to cardiovascular disease (CVD). Both amino acids can be reduced in vivo by estrogen. Variation in the estrogen receptor (ER) may influence homocysteine and ADMA, yet no information is available on associations with single nucleotide polymorphisms in the estrogen receptor genes ERalpha (PvuII and XbaI) and ERbeta (1730G-->A and cx + 56 G-->A).
Original language | English |
---|---|
Pages (from-to) | 215-23 |
Number of pages | 9 |
Journal | Climacteric : the Journal of the International Menopause Society |
Volume | 9 |
Issue number | 3 |
DOIs | |
Publication status | Published - Jun 2006 |
Keywords
- Aged
- Arginine
- Body Mass Index
- Cardiovascular Diseases
- Cross-Sectional Studies
- Estrogen Receptor alpha
- Estrogen Receptor beta
- Female
- Folic Acid
- Genetic Variation
- Genotype
- Homocysteine
- Humans
- Linkage Disequilibrium
- Middle Aged
- Nitric Oxide
- Nitric Oxide Synthase
- Polymorphism, Single Nucleotide
- Postmenopause
- Risk Factors
- Vitamin B 12